EIGR

Eiger BioPharmaceuticals, Inc.
EIGR

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

EIGR was delisted on the 10th of April, 2024.

Back to rankings

39 hedge funds and large institutions have $39.6M invested in Eiger BioPharmaceuticals, Inc. in 2017 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

less funds holding in top 10

Funds holding in top 10: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

40% less capital invested

Capital invested by funds: $66.2M → $39.6M (-$26.7M)

Holders
39
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$400K
2
+$365K
3
+$316K
4
Goldman Sachs
Goldman Sachs
New York
+$272K
5
Renaissance Technologies
Renaissance Technologies
New York
+$185K

Top Sellers

1
-$4.06M
2
-$3.02M
3
-$1.23M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$1.06M
5
Northern Trust
Northern Trust
Illinois
-$472K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$79K
27
$57K
28
$56K
29
$34K
30
$31K
31
$23K
32
$5K
33
$4K
34
$3K
35
$1K
36
$1K
37
$1K
38
$498
39
–
40
–
41
–
42
–
43
–
44
–
45
–
46
–
47
–
48
–
49
–
50
–
1
2
3